Inventor · disambiguated record
Taro Miyazaki
Also filed as: MIYAZAKI TARO
14 granted patents·21 pending applications·204 citations·filing 1998–2025
92Inventor score
Files withCHUGAI PHARMACEUTICAL CO LTD22ROCHE VITAMINS INC5HATTORI KUNIHIRO3DSM IP ASSETS BV2MIYAZAKI TARO1
Top patents by PatentIndex Score
35 records- 0193US8062635B2Bispecific antibody substituting for functional proteinsHATTORI KUNIHIRO·Filed 2004·Granted Nov 22, 2011·95 cites·33 claims
- 0292US7135315B2Aldehyde dehydrogenase geneDSM IP ASSETS BV·Filed 2003·Granted Nov 14, 2006·33 cites·14 claims
- 0392US2025026854A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0490US11485790B2Immunoactivating antigen-binding moleculeCHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Granted Nov 1, 2022·6 cites·8 claims
- 0590US2024190997A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0688US11952422B2Antigen-binding molecule comprising altered antibody variable region binding CD3 and CD137CHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Apr 9, 2024·4 cites·15 claims
- 0788US2023348621A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0887US2025270345A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 0985US8597911B2Process for producing antibodiesMIYAZAKI TARO·Filed 2004·Granted Dec 3, 2013·21 cites·14 claims
- 1083US12304960B2Anti-CD137 antigen-binding molecule and utilization thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted May 20, 2025·3 cites·27 claims
- 1182US11660340B2Combination therapy using T cell redirection antigen binding molecule against cell having immunosuppressing functionCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Granted May 30, 2023·2 cites·2 claims
- 1282US2022213217A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1379US2021380717A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1478US6444449B1D-sorbitol dehydrogenase geneROCHE VITAMINS INC·Filed 2000·Granted Sep 3, 2002·5 cites·39 claims
- 1578US6127156AD-sorbitol dehydrogenase geneROCHE VITAMINS INC·Filed 1998·Granted Oct 3, 2000·18 cites·37 claims
- 1677US2021107995A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1774US2020277402A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1873US2019359728A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1971US2019112390A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 2070US6653115B1D-sorbitol dehydrogenase geneROCHE VITAMINS INC·Filed 2000·Granted Nov 25, 2003·1 cites·49 claims
- 2170US2018244800A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 2269US6242233B1Aldehyde dehydrogenaseROCHE VITAMINS INC·Filed 1998·Granted Jun 5, 2001·12 cites·5 claims
- 2369US2023151112A1Immunoactivating antigen-binding moleculeCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2468US2018002443A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 2567US2024270846A1Antigen-binding molecule comprising altered antibody variable region binding cd3 and cd137CHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 2666US2017145111A1Antibody Substituting for Function of Blood Coagulation Factor VIIICHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 2762US2025388689A1Anti-cd137 antigen-binding molecule and utilization thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 2862US2010003254A1Antibody Substituting for Function of Blood Coagulation Factor VIIICHUGAI PHARMACEUTICAL CO LTD·Filed 2006·Application pending·0 cites
- 2960US2012237517A1Antibody Substituting for Function of Blood Coagulation Factor VIIIHATTORI KUNIHIRO·Filed 2012·Application pending·0 cites
- 3052US6924872B2Flexible LCD panel fabrication method and flexible LCD panel fabrication system used for the sameSHARP KK·Filed 2000·Granted Aug 2, 2005·4 cites·48 claims
- 3150US7544494B2Vitamin C from sorbosoneDSM IP ASSETS BV·Filed 2003·Granted Jun 9, 2009·0 cites·8 claims
- 3250US6846660B2Method of making an aldehyde dehydrogenase with gluconobacterROCHE VITAMINS INC·Filed 2001·Granted Jan 25, 2005·0 cites·3 claims
- 3349US2005153412A1Aldehyde dehydrogenase IIFiled 2003·Application pending·0 cites
- 3439US2008075712A1Double Specific Antibodies Substituting For Functional ProteinsHATTORI KUNIHIRO·Filed 2003·Application pending·0 cites
- 3538US2018171017A1Combined use of immune activatorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Taro Miyazaki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →